Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog
出版年份 2019 全文链接
标题
Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 39, Issue 4, Pages 694-703
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-02-07
DOI
10.1161/atvbaha.118.311758
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PAR4 (Protease-Activated Receptor 4)
- (2018) Xu Han et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet TherapeuticsHighlights
- (2018) Benjamin E. Tourdot et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
- (2018) Gamariel Rwibasira Rudinga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current and future antiplatelet therapies: emphasis on preserving haemostasis
- (2018) James D. McFadyen et al. Nature Reviews Cardiology
- Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
- (2017) Carlo Patrono et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4
- (2017) HongBin Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
- (2017) Pancras C. Wong et al. Science Translational Medicine
- Targeting PAR1: Now What?
- (2017) Robert Flaumenhaft et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Recent innovations in the structural analysis of heparin
- (2016) Edwin A. Yates et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Old and new applications of non-anticoagulant heparin
- (2016) Giuseppe Cassinelli et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist
- (2015) Brian E. Hawes et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CLL2-1, a chemical derivative of orchid 1,4-phenanthrenequinones, inhibits human platelet aggregation through thiol modification of calcium-diacylglycerol guanine nucleotide exchange factor-I (CalDAG-GEFI)
- (2015) Chieh-Yu Liao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?
- (2014) Kurt Huber et al. AMERICAN HEART JOURNAL
- Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
- (2014) L. C. Edelstein et al. BLOOD
- Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis
- (2014) M. M. Mumaw et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel antiplatelet agents in acute coronary syndrome
- (2014) Francesco Franchi et al. Nature Reviews Cardiology
- Thrombin-induced platelet activation via PAR4: pivotal role for exosite II
- (2014) Niklas Boknäs et al. THROMBOSIS AND HAEMOSTASIS
- The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation
- (2010) Chin-Chung Wu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Heparin/heparan sulphate-based drugs
- (2010) Neha S. Gandhi et al. DRUG DISCOVERY TODAY
- Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood
- (2010) G. L. MENDOLICCHIO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets
- (2010) C.-C. Wu et al. THROMBOSIS AND HAEMOSTASIS
- Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib
- (2010) Alessandro Zarpellon et al. THROMBOSIS AND HAEMOSTASIS
- The anti-inflammatory effects of heparin and related compounds
- (2007) Edward Young THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now